Trials / Completed
CompletedNCT05084599
Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section
Effect of 90% Effective Dose of Metaraminol in Supine and Left Tilt Positions on Cesarean Section:A Non-inferiority Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 124 (actual)
- Sponsor
- Peking University People's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
For hypotension after spinal anesthesia, metaraminol has different 90% effective doses in the supine position and the left-tilt position. We plan to conduct a non-inferiority trial to compare the effects of the two on the fetus and the mother.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metaraminol 2.7μg/kg/min | After spinal anesthesia, the patient was placed in a supine position until the fetus was delivered, and metaraminol was given at an initial rate of 2.7μg/kg/min throughout the process. |
| DRUG | Metaraminol 2μg/kg/min | After spinal anesthesia, the patient was placed in left-tilt position until the fetus was delivered, and metaraminol was given at an initial rate of 2μg/kg/min throughout the process. |
Timeline
- Start date
- 2022-05-12
- Primary completion
- 2024-01-31
- Completion
- 2024-01-31
- First posted
- 2021-10-20
- Last updated
- 2024-02-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05084599. Inclusion in this directory is not an endorsement.